Crouse Health Online: Wellness is just a click away.
Share Share
  |  Connect with Us: 
large
med
small
Text Size
 

Health News



Extra Tests Not a Deterrent to Experimental Cancer Therapy

Extra Tests Not a Deterrent to Experimental Cancer Therapy

03/04/11

FRIDAY, March 4 (HealthDay News) -- Cancer patients are willing to tolerate multiple needle pokes, X-rays, ultrasounds, PET and CT scans to receive advanced experimental treatments in early-stage clinical trials, with some even amenable to extra tumor biopsies, according to a new study.

The finding from interviews with 61 patients with advanced cancer suggests a promising future for personalized medicine, in which doctors use specific treatments based on the genetic makeup of patients' tumors.

The study, conducted by researchers at the Mayo Clinic, Scottsdale Healthcare and the Translational Genomics Research Institute in Arizona, appears online and in the July 15 print issue of the journal Cancer.

"This is the first study of its kind where patients themselves were asked what tests and medical imaging studies they would be willing to undergo while participating in clinical studies for their cancer. Patients also were asked how invasive they perceived such tests and studies [to be]," lead author Dr. Raoul Tibes, a physician-scientist for the Mayo Clinic in Arizona, said in a Translational Genomics Research Institute news release.

To gain a better understanding about the molecular aspects of cancer, scientists need to collect tumor samples and analyze images from tests such as CT, MRI and PET scans.

"What we learned is that patients are, in general, very willing to undergo additional, extra tests to participate in clinical studies," Tibes said.

The patients said they were most willing to undergo urine, blood, ultrasound, X-ray, echocardiogram, PET and CAT scan tests. They were least willing to undergo tumor and skin biopsies and MRIs. However, most patients were willing to give one tumor biopsy sample per study, and sometimes two per study.

"This is important information, because it tells us that we can design clinical studies that ask patients to give extra tumor biopsies. But we need to carefully judge how many biopsies we request and what molecular tests we do with the tumor sample," senior study author Dr. Mitesh J. Borad, M.D., associate director of phase 1 drug development at the Mayo Clinic, said in the news release.

More information

The U.S. National Cancer Institute has more about personalized cancer care.

Copyright © 2011 HealthDay. All rights reserved.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.

OF INTEREST:
 

Latest News

Crouse Hospital First in Region to Use New da Vinci Xi Surgical System
more >

MedEx Bedside Prescription Delivery Service

Free service offers convenience, patient education at discharge.
more >

CrouseSports Express After-Hours Ortho Care

Immediate care of orthopedic injuries in kids and adults.
more >

Weight Loss Surgery

Is it right for you? Attend a free information seminar held twice monthly.
more >

Quality at Crouse

See how Crouse Hospital strives to provide the best in patient care.
more >

Cheer Up That Special Someone

Say get well or welcome a new arrival with a gift purchased right at Crouse.

more >

Make an Online Donation Now

Your donation of any amount helps support Crouse services & programs in a meaningful way.
more >

Shop Online Now

Say get well, thinking of you or welcome new baby with a unique gift from the Crouse Gift Shop.

more >